| COVID-19 |
1 |
1 |
| Blood |
0 |
0.99 |
| Michigan |
0 |
0.39 |
| Blood Vessel |
0 |
0.37 |
| Adhesion |
0 |
0.26 |
| Antiphospholipid Syndrome |
0 |
0.98 |
| Hospital |
0 |
0.26 |
| Pennsylvania |
0 |
0.26 |
| Plasma |
0 |
0.26 |
| Thrombosis |
0 |
0.26 |
| Anticoagulation Therapy |
0 |
0.22 |
| Thromboembolism |
0 |
0.16 |
| Arthritis |
0 |
0.13 |
| Autopsy |
0 |
0.13 |
| Coagulation |
0 |
0.13 |
| Enzyme-Linked Immunosorbent Assay (ELISA) |
0 |
0.13 |
| Grant |
0 |
0.13 |
| Heart |
0 |
0.13 |
| Immunobiology |
0 |
0.13 |
| Immunoglobulin G (IgG) |
0 |
0.13 |
| Lung |
0 |
0.13 |
| Neutrophils |
0 |
0.13 |
| Pandemic |
0 |
0.13 |
| Plasmapheresis |
0 |
0.13 |
| Respiratory Failure |
0 |
0.13 |
| Severe Acute Respiratory Syndrome |
0 |
0.13 |
| Sepsis |
0 |
0.11 |
| Acute Respiratory Distress Syndrome |
0 |
0.06 |
| Biologic Therapy |
0 |
0.06 |